CIK 0001274737 · Services-Medical Laboratories (SIC 8071) · Nasdaq · incorporated in DE · fiscal year ends 12/31
| FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|
| Revenue (USD) | 66.6 M | 52.5 M | 45.6 M | |
| Net income (USD) | -47.4 M | -26.9 M | ||
| Diluted EPS (USD/shares) | -0.93 | -1.34 | -2.77 |
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-10-20 | 4 | 4 | 2026-10-19 |
| 2026-10-19 | 4 | FORM 4 | 2026-10-16 |
| 2026-10-19 | 3 | OWNERSHIP DOCUMENT | 2026-10-16 |
| 2026-09-02 | 4 | FORM 4 | 2026-09-01 |
| 2026-08-24 | 4/A | FORM 4/A | 2026-06-09 |
| 2026-08-19 | 4 | FORM 4 | 2026-06-09 |
| 2026-08-19 | 4 | FORM 4 | 2026-06-09 |
| 2026-08-04 | 10-Q | 10-Q | 2026-06-30 |
| 2026-08-04 | 8-K | 10-Q items 2.02,9.01 | 2026-08-04 |
| 2026-06-22 | 4 | FORM 4 | 2026-06-09 |
| 2026-06-22 | 4 | FORM 4 | 2026-06-09 |
| 2026-06-22 | 4 | FORM 4 | 2026-06-09 |
| 2026-06-09 | 8-K | 8-K items 5.07 | 2026-06-09 |
| 2026-05-27 | SCHEDULE 13G | SCHEDULE 13G | |
| 2026-05-20 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-05-12 | S-8 | S-8 | |
| 2026-05-11 | 10-Q | 10-Q | 2026-03-31 |
| 2026-05-11 | 8-K | 8-K items 2.02,9.01 | 2026-05-11 |
| 2026-04-27 | ARS | ARS | 2025-12-31 |
| 2026-04-27 | DEFA14A | DEFA14A | |
| 2026-04-27 | DEF 14A | DEF 14A | 2026-06-09 |
| 2026-04-23 | 8-K | 8-K items 5.02,9.01 | 2026-04-17 |
| 2026-04-21 | 3/A | FORM 3/A | 2025-07-17 |
| 2026-03-16 | 3 | FORM 3 | 2026-03-16 |
| 2026-03-16 | 4 | FORM 4 | 2026-03-12 |
Forms on file (last 1,000): 4 135, 8-K 73, SC 13G/A 29, 3 25, D 24, 10-Q 21, SC 13G 9, SCHEDULE 13G/A 8. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=XGN (0.002 USD), /gw/filings/filings?ticker=XGN&form=8-K, /gw/filings/facts?ticker=XGN&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange